POA
AGN

Pergamon Offshore Advisors’s Allergan Inc AGN Stock Holding History

Pergamon Offshore Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,718
Closed -$1.01M – 160
2015
Q3 		$1.01M Buy
3,718
+3,021
+433% +$821K 1.1% 20
2015
Q2 		$212K Buy
+697
New +$212K 0.22% 146

Other funds holding AGN

SL
Summitry LLC Foster City, California $3.04B AUM 17.05% 1-Year Est. Return
AWM
Altavista Wealth Management Asheville, North Carolina $496M AUM 20.88% 1-Year Est. Return
III
Independent Investors Inc Nesconset, New York $524M AUM 29.67% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
ODCM
Old Dominion Capital Management Charlottesville, Virginia $467M AUM 25.94% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
HHAA
Henry H. Armstrong Associates Pittsburgh, Pennsylvania $1.03B AUM 4.23% 1-Year Est. Return
AGA
Accuvest Global Advisors Provo, Utah $107M AUM 6.41% 1-Year Est. Return
LCM
Liberty Capital Management Birmingham, Michigan $582M AUM

Pergamon Offshore Advisors's AGN Position: Q4 2015 in Review

Pergamon Offshore Advisors sold out of Allergan Inc (AGN) in Q4 2015, closing a stake of 3,718 shares — an estimated $1.01M sold.

Pergamon Offshore Advisors first reported a position in AGN in Q2 2015 and held it in 2 quarters. The position peaked at $1.01M in Q3 2015. 28 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Pergamon Offshore Advisors reported no remaining Allergan Inc position as of Q4 2015 after selling out during the quarter.
  • Pergamon Offshore Advisors sold 3,718 Allergan Inc shares in Q4 2015, an estimated $1.01M.
  • Pergamon Offshore Advisors first reported a position in Allergan Inc in Q2 2015 and held it in 2 quarters.
  • Pergamon Offshore Advisors's Allergan Inc position peaked at $1.01M in Q3 2015.
  • 28 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2015.

Based on Pergamon Offshore Advisors's 13F filing for Q4 2015.